Sleep-disordered breathing, type 2 diabetes and the metabolic syndrome

Chronic Respiratory Disease

Volumn 11, Issue 4, 2014, Pages 257-275

  Seetho, Ian W ^a   Wilding, John P H ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

metabolic syndrome; obstructive sleep apnoea; Sleep disordered breathing; type 2 diabetes

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; CATECHOLAMINE; CHOLESTEROL; CYTOKINE; GLUCOSE; GROWTH HORMONE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INSULIN; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OREXIN; REACTIVE OXYGEN METABOLITE; TRIACYLGLYCEROL;

AUTONOMIC NERVOUS SYSTEM FUNCTION; BARIATRIC SURGERY; BODY MASS; CARDIOMETABOLIC RISK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIABETES EDUCATION; DIABETIC MACULAR EDEMA; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DYSLIPIDEMIA; ENDOCRINE FUNCTION; EPWORTH SLEEPINESS SCALE; EXERCISE; GLUCOSE INTOLERANCE; GLYCEMIC CONTROL; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; HYPERVENTILATION; HYPOCAPNIA; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; HYPOXEMIA; IMPAIRED GLUCOSE TOLERANCE; INFLAMMATION; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTERMITTENT HYPOXIA; LIFESTYLE MODIFICATION; LOW CALORY DIET; META ANALYSIS (TOPIC); METABOLIC SYNDROME X; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PHYSICAL ACTIVITY; POSITIVE END EXPIRATORY PRESSURE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY DISTURBANCE INDEX; REVIEW; SLEEP DISORDERED BREATHING; SLEEP TIME; SYMPATHETIC TONE; SYSTEMATIC REVIEW (TOPIC); WEIGHT REDUCTION; BLOOD; DIABETES MELLITUS; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; METABOLISM; SLEEP APNEA, OBSTRUCTIVE;

ADIPOKINES; CONTINUOUS POSITIVE AIRWAY PRESSURE; DIABETES MELLITUS; DYSLIPIDEMIAS; HUMANS; HYPERTENSION; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INFLAMMATION; INSULIN RESISTANCE; METABOLIC SYNDROME X; OBESITY; OXIDATIVE STRESS; PITUITARY-ADRENAL SYSTEM; SLEEP APNEA, OBSTRUCTIVE; WEIGHT LOSS;

EID: 84912045033     PISSN: 14799723     EISSN: 14799731     Source Type: Journal    
DOI: 10.1177/1479972314552806     Document Type: Review

References (151)

1. Shaw JE, Punjabi NM, Wilding JP, et al. Sleep-disordered breathing and type 2 diabetes: a report from the international diabetes federation taskforce on epidemiology and prevention. Diabetes Res Clin Pract. 2008 ; 81 ((1)). 2-12
2. Nieto FJ, Peppard PE, Young TB. Sleep disordered breathing and metabolic syndrome. Wisc Med J. 2009 ; 108 ((5)). 263-265
3. Beebe DW, Groesz L, Wells C, et al. The neuropsychological effects of obstructive sleep apnea: a meta-analysis of norm-referenced and case-controlled data. Sleep. 2003 ; 26 ((3)). 298-307
4. Young T, Palta M, Dempsey J, et al. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med. 1993 ; 328 ((17 )). 1230-1235
5. Tasali E, Ip MSM. Obstructive sleep apnea and metabolic syndrome: alterations in glucose metabolism and inflammation. Proc Am Thorac Soc. 2008 ; 5 ((2)). 207-217
6. Flemons WW, Littner MR, Rowley JA, et al. Home diagnosis of sleep apnea: a systematic review of the literature. An evidence review cosponsored by the American Academy of Sleep Medicine, the American College of Chest Physicians, and the American Thoracic Society. Chest. 2003 ; 124 ((4)). 1543-1579
7. Caples SM, Gami AS, Somers VK. Obstructive sleep apnea. Ann Intern Med. 2005 ; 142 ((3 )). 187-197
8. Flemons WW, Buysse D, Redline S, et al. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. Sleep. 1999 ; 22 ((5)). 667-689
9. Peppard PE, Young T, Barnet JH, et al. Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol. 2013 ; 177 ((9 )). 1006-1014
10. Malhotra A, White DP. Obstructive sleep apnoea. Lancet. 2002 ; 360 (9328). 237-245
11. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004 ; 363 ((9403)). 157-163
12. Schwartz AR, Patil SP, Laffan AM, et al. Obesity and obstructive sleep apnea: pathogenic mechanisms and therapeutic approaches. Proc Am Thorac Soc. 2008 ; 5 ((2)). 185-192
13. Peppard PE, Young T, Palta M, et al. Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA. 2000 ; 284 ((23)). 3015-3021
14. Tasali E, Mokhlesi B, Van Canter E. Obstructive sleep apnea and type 2 diabetes: interacting epidemics. Chest. 2008 ; 133 ((2 )). 496-506
15. Heffner JE, Rozenfeld Y, Kai M, et al. Prevalence of diagnosed sleep apnea among patients with type 2 diabetes in primary care. Chest. 2012 ; 141 ((6)). 1414-1421
16. West SD, Nicoll DJ, Stradling JR. Prevalence of obstructive sleep apnoea in men with type 2 diabetes. Thorax. 2006 ; 61 ((11 )). 945-950
17. Foster GD, Sanders MH, Millman R, et al. Obstructive sleep apnea among obese patients with type 2 diabetes. Diabetes Care. 2009 ; 32 ((6 )). 1017-1022
18. Zimmet P, Alberti K, Shaw J. Global and societal implications of the diabetes epidemic. Nature. 2001 ; 414 ((6865 )). 782-787
19. Reaven GM. Role of insulin resistance in human disease. Diabetes. 1988 ; 37 ((12 )). 1595-1607
20. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005 ; 365 ((9468 )). 1415-1428
21. Alberti K, Zimmet PZ.. Definition, diagnosis and classification of diabetes mellitus and its complications part 1: diagnosis and classification of diabetes mellitus: provisional report of a WHO consultation. Diabet Med. 1998 ; 15: 539-553
22. Balkau B, Charles MA. Comment on the provisional report from the WHO consultation. Diabet Med. 1999 ; 16: 442-443
23. Cleeman JI, Grundy SM, Becker D, et al. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001 ; 285: 2486-2497
24. Alberti K, Zimmet P, Shaw J. The metabolic syndrome: a new worldwide definition. Lancet. 2005 ; 366: 1059-1062
25. Alberti K, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention, National Heart, Lung, and Blood Institute, American Heart Association, World Heart Federation, International Atherosclerosis Society, and International Association for the Study of Obesity. Circulation. 2009 ; 120 ((16)). 1640-1645
26. Coughlin SR, Mawdsley L, Mugarza JA, et al. Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J. 2004 ; 25 ((9)). 735-741
27. Wilcox I, McNamara SG, Collins FL, et al. "Syndrome Z": the interaction of sleep apnoea, vascular risk factors and heart disease. Thorax. 1998 ; 53: S25 - S28
28. Bonsignore MR, Esquinas C, Barcelo A, et al. Metabolic syndrome, insulin resistance and sleepiness in real-life obstructive sleep apnoea. Eur Resp J. 2012 ; 39 ((5)). 1136-1143
29. Knutson KL, Spiegel K, Penev P, et al. The metabolic consequences of sleep deprivation. Sleep Med Rev. 2007 ; 11 ((3 )). 163-178
30. Ip MSM, Lam B, Ng MMT, et al. Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med. 2002 ; 165 ((5)). 670-676
31. Punjabi NM, Sorkin JD, Katzel LI, et al. Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med. 2002 ; 165 ((5)). 677-682
32. Punjabi NM, Shahar E, Redline S, et al. Sleep-disordered breathing, glucose intolerance, and insulin resistance: the sleep heart health study. Am J Epidemiol. 2004 ; 160 ((6)). 521-530
33. Reichmuth KJ, Austin D, Skatrud JB, et al. Association of sleep apnea and type II diabetes: a population-based study. Am J Respir Crit Care Med. 2005 ; 172 ((12)). 1590-1595
34. Botros N, Concato J, Mohsenin V, et al. Obstructive sleep apnea as a risk factor for type 2 diabetes. Am J Med. 2009 ; 122 ((12 )). 1122-1127
35. Tamura A, Kawano Y, Watanabe T, et al. Obstructive sleep apnea increases hemoglobin A1c levels regardless of glucose tolerance status. Sleep Med. 2012 ; 13 ((8)). 1050-1055
36. Lindberg E, Theorell-Haglow J, Svensson M, et al. Sleep apnea and glucose metabolism a long-term follow-up in a community-based sample. Chest. 2012 ; 142 ((4)). 935-942
37. Kent BD, Grote L, Ryan S, et al. Diabetes mellitus prevalence and control in sleep disordered breathing: the European Sleep Apnea Cohort (ESADA) study. Chest. :
38. Kendzerska T, Gershon AS, Hawker G, et al. Obstructive sleep apnea and incident diabetes: a historical cohort study. Am J Respir Crit Care Med. 2014 ; 190 ((2)). 218-225
39. Vgontzas AN, Papanicolaou DA, Bixler EO, et al. Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab. 2000 ; 85 ((3)). 1151-1158
40. Onat A, Hergenc G, Uyarel H, et al. Obstructive sleep apnea syndrome is associated with metabolic syndrome rather than insulin resistance. Sleep Breath. 2007 ; 11 ((1)). 23-30
41. Gruber A, Horwood F, Sithole J, et al. Obstructive sleep apnoea is independently associated with the metabolic syndrome but not insulin resistance state. Cardiovasc Diabetol. 2006 ; 5: 22
42. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010 ; 87 ((1 )). 4-14
43. Lin QC, Zhang XB, Chen GP, et al. Obstructive sleep apnea syndrome is associated with some components of metabolic syndrome in nonobese adults. Sleep Breath. 2012 ; 16 ((2)). 571-578
44. Dadoun F, Darmon P, Achard V, et al. Effect of sleep apnea syndrome on the circadian profile of cortisol in obese men. Am J Physiol - Endocrinol Metab. 2007 ; 293 ((2)). E466 - E474
45. Buyukaydin B, Akkoyunlu ME, Kazancioglu R, et al. The effect of sleep apnea syndrome on the development of diabetic nephropathy in patients with type 2 diabetes. Diabetes Res Clin Pract. 2012 ; 98 ((1)). 140-143
46. Mason RH, West SD, Kiire CA, et al. High prevalence of sleep disordered breathing in patients with diabetic macular edema. Retina. 2012 ; 32 ((9)). 1791-1798
47. Drager LF, Jun JC, Polotsky VY. Metabolic consequences of intermittent hypoxia: relevance to obstructive sleep apnea. Best Pract Res Clin Endocrinol Metab. 2010 ; 24 ((5)). 843-851
48. Punjabi NM, Polotsky VY. Disorders of glucose metabolism in sleep apnea. J Appl Physiol. 2005 ; 99 ((5 )). 1998-2007
49. Iiyori N, Alonso LC, Li JG, et al. Intermittent hypoxia causes insulin resistance in lean mice independent of autonomic activity. Am J Respir Crit Care Med. 2007 ; 175 ((8)). 851-857
50. Polotsky VY, Li JG, Punjabi NM, et al. Intermittent hypoxia increases insulin resistance in genetically obese mice. J Physiol (Lond). 2003 ; 552 ((1)). 253-264
51. Bastard JP, Maachi M, Van Nhieu JT, et al. Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro. J Clin Endocrinol Metab. 2002 ; 87 ((5)). 2084-2089
52. Morselli L, Leproult R, Balbo M, et al. Role of sleep duration in the regulation of glucose metabolism and appetite. Best Pract Res Clin Endocrinol Metab. 2010 ; 24 ((5)). 687-702
53. Oltmanns KM, Gehring H, Rudolf S, et al. Hypoxia causes glucose intolerance in humans. Am J Respir Crit Care Med. 2004 ; 169 ((11 )). 1231-1237
54. Gottlieb DJ, Punjabi NM, Newman AB, et al. Association of sleep time with diabetes mellitus and impaired glucose tolerance. Arch Intern Med. 2005 ; 165 ((8)). 863-868
55. Wolk R, Svatikova A, Nelson CA, et al. Plasma levels of adiponectin, a novel adipocyte-derived hormone, in sleep apnea. Obes Res. 2005 ; 13 (1). 186-190
56. West SD, Groves DC, Lipinski HJ, et al. The prevalence of retinopathy in men with type 2 diabetes and obstructive sleep apnoea. Diabet Med. 2010 ; 27 ((4)). 423-430
57. Somers VK, Dyken ME, Clary MP, et al. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest. 1995 ; 96 ((4 )). 1897-1904
58. Li JG, Thorne LN, Punjabi NM, et al. Intermittent hypoxia induces hyperlipidemia in lean mice. Circ Res. 2005 ; 97 ((7 )). 698-706
59. Li JG, Grigoryev DN, Ye SQ, et al. Chronic intermittent hypoxia upregulates genes of lipid biosynthesis in obese mice. J Appl Physiol. 2005 ; 99 ((5)). 1643-1648
60. Vgontzas AN, Bixier EO, Chrousos GP. Sleep apnea is a manifestation of the metabolic syndrome. Sleep Med Rev. 2005 ; 9: 211-224
61. Meston N, Davies RJO, Mullins R, et al. Endocrine effects of nasal continuous positive airway pressure in male patients with obstructive sleep apnoea. J Intern Med. 2003 ; 254 ((5)). 447-454
62. Vgontzas AN, Pejovic S, Zoumakis E, et al. Hypothalamic-pituitary-adrenal axis activity in obese men with and without sleep apnea: effects of continuous positive airway pressure therapy. J Clin Endocrinol Metab. 2007 ; 92 ((11)). 4199-4207
63. Lavie L. Oxidative stress - a unifying paradigm in obstructive sleep apnea and comorbidities. Prog Cardiovasc Dis. 2009 ; 51 ((4 )). 303-312
64. Louis M, Punjabi NM. Effects of acute intermittent hypoxia on glucose metabolism in awake healthy volunteers. J Appl Physiol. 2009 ; 106 ((5)). 1538-1544
65. Imadojemu VA, Mawji Z, Kunselman A, et al. Sympathetic chemoreflex responses in obstructive sleep apnea and effects of continuous positive airway pressure therapy. Chest. 2007 ; 131 ((5)). 1406-1413
66. Narkiewicz K, Somers VK. Sympathetic nerve activity in obstructive sleep apnoea. Acta Physiol Scand. 2003 ; 177 ((3 )). 385-390
67. Kohler M, Stradling JR. Mechanisms of vascular damage in obstructive sleep apnea. Nat Rev Cardiol. 2010 ; 7 ((12 )). 677-685
68. Delarue J, Magnan C. Free fatty acids and insulin resistance. Curr Opin Clin Nutr Metab Care. 2007 ; 10 ((2 )). 142-148
69. Lanfranco F, Motta G, Minetto MA, et al. Neuroendocrine alterations in obese patients with sleep apnea syndrome. Int J Endocrinol. 2010 ; 2010: 474-518
70. Rosmond R. Stress induced disturbances of the HPA axis: a pathway to type 2 diabetes?. Med Sci Monit. 2003 ; 9 (2). RA35 - RA39
71. Lanfranco F, Gianotti L, Pivetti S, et al. Obese patients with obstructive sleep apnoea syndrome show a peculiar alteration of the corticotroph but not of the thyrotroph and lactotroph function. Clin Endocrinol. 2004 ; 60 ((1)). 41-48
72. Spiegel K, Leproult R, Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet. 1999 ; 354 ((9188 )). 1435-1439
73. Buckley TM, Schatzberg AF. Review: on the interactions of the hypothalamic-pituitary-adrenal (HPA) axis and sleep: normal HPA axis activity and circadian rhythm, exemplary sleep disorders. J Clin Endocrinol Metab. 2005 ; 90 ((5)). 3106-3114
74. Schmoller A, Eberhardt F, Jauch-Chara K, et al. Continuous positive airway pressure therapy decreases evening cortisol concentrations in patients with severe obstructive sleep apnea. Metabolism. 2009 ; 58 ((6)). 848-853
75. Xu J, Long YS, Gozal D, et al. Beta-cell death and proliferation after intermittent hypoxia: role of oxidative stress. Free Radic Biol Med. 2009 ; 46 ((6)). 783-790
76. Lavie L. Obstructive sleep apnoea syndrome: an oxidative stress disorder. Sleep Med Rev. 2003 ; 7 ((1 )). 35-51
77. Calvin AD, Albuquerque FN, Lopez-Jimenez F, et al. Obstructive sleep apnea, inflammation, and the metabolic syndrome. Metab Syndr Relat Disord. 2009 ; 7 ((4)). 271-277
78. Alam I, Lewis K, Stephens JW, et al. Obesity, metabolic syndrome and sleep apnoea: all pro-inflammatory states. Obes Rev. 2007 ; 8 ((2 )). 119-127
79. Kern PA, Ranganathan S, Li CL, et al. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol - Endocrinol Metab. 2001 ; 280 ((5)). E745 - E751
80. Moller DE. Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes. Trends Endocrinol Metab. 2000 ; 11 ((6 )). 212-217
81. Ceddia RB, Koistinen HA, Zierath JR, et al. Analysis of paradoxical observations on the association between leptin and insulin resistance. FASEB J. 2002 ; 16 ((10 )). 1163-1176
82. Trujillo ME, Scherer PE. Adiponectin - journey from an adipocyte secretory protein to biomarker of the metabolic syndrome. J Intern Med. 2005 ; 257 ((2)). 167-175
83. Harsch IA, Wallaschofski H, Koebnick C, et al. Adiponectin in patients with obstructive sleep apnea syndrome: course and physiological relevance. Respiration. 2004 ; 71 ((6)). 580-586
84. Ip MSM, Lam KSL, Ho CM, et al. Serum leptin and vascular risk factors in obstructive sleep apnea. Chest. 2000 ; 118 ((3 )). 580-586
85. Lui MMS, Ip MSM. Disorders of glucose metabolism in sleep-disordered breathing. Clin Chest Med. 2010 ; 31 ((2 )). 271-285
86. Magalang UJ, Cruff JP, Rajappan R, et al. Intermittent hypoxia suppresses adiponectin secretion by adipocytes. Exp Clin Endocrinol Diabetes. 2009 ; 117 ((3)). 129-134
87. Spiegel K, Tasali E, Leproult R, et al. Effects of poor and short sleep on glucose metabolism and obesity risk. Nat Rev Endocrinol. 2009 ; 5 ((5)). 253-261
88. Tahrani AA, Ali A, Raymonds NT, et al. Obstructive sleep apnea and diabetic neuropathy a novel association in patients with type 2 diabetes. Am J Respir Crit Care Med. 2012 ; 186 ((5)). 434-441
89. Furukawa S, Saito I, Yamamoto S, et al. Nocturnal intermittent hypoxia as an associated risk factor for microalbuminuria in Japanese patients with type 2 diabetes mellitus. Eur J Endocrinol. 2013 ; 169 ((2)). 239-246
90. Lam JCM, Mak JCW, Ip MSM. Obesity, obstructive sleep apnoea and metabolic syndrome. Respirology. 2012 ; 17 ((2 )). 223-236
91. Basoglu OK, Sarac F, Sarac S, et al. Metabolic syndrome, insulin resistance, fibrinogen, homocysteine, leptin, and C-reactive protein in obese patients with obstructive sleep apnea syndrome. Ann Thorac Med. 2011 ; 6 ((3)). 120-125
92. Lam JCM, Lam B, Lam CL, et al. Obstructive sleep apnea and the metabolic syndrome in community-based Chinese adults in Hong Kong. Respir Med. 2006 ; 100 ((6)). 980-987
93. Kono M, Tatsumi K, Saibara T, et al. Obstructive sleep apnea syndrome is associated with some components of metabolic syndrome. Chest. 2007 ; 131 ((5)). 1387-1392
94. Peled N, Kassirer M, Shitrit D, et al. The association of OSA with insulin resistance, inflammation and metabolic syndrome. Respir Med. 2007 ; 101 ((8)). 1696-1701
95. Ho JS, Cannaday JJ, Barlow CE, et al. Relation of the number of metabolic syndrome risk factors with all-cause and cardiovascular mortality. Am J Cardiol. 2008 ; 102 ((6)). 689-692
96. Sundstrom J, Vallhagen E, Riserus U, et al. Risk associated with the metabolic syndrome versus the sum of its individual components. Diabetes Care. 2006 ; 29 ((7)). 1673-1674
97. Bjorntorp P. Metabolic implications of body-fat distribution. Diabetes Care. 1991 ; 14 ((12 )). 1132-1143
98. Isono S. Obesity and obstructive sleep apnoea: mechanisms for increased collapsibility of the passive pharyngeal airway. Respirology. 2012 ; 17 ((1)). 32-42
99. Punjabi NM. The epidemiology of adult obstructive sleep apnea. Proc Am Thorac Soc. 2008 ; 5 ((2 )). 136-143
100. Fogel RB, Malhotra A, White DP. Pathophysiology of obstructive sleep apnoea/hypopnoea syndrome. Thorax. 2004 ; 59 ((2 )). 159-163
101. Peppard PE, Young T, Palta M, et al. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med. 2000 ; 342 ((19)). 1378-1384
102. Lavie P, Herer P, Hoffstein V. Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study. Br Med J. 2000 ; 320 ((7233)). 479-482
103. Marin JM, Agusti A, Villar I, et al. Association between treated and untreated obstructive sleep apnea and risk of hypertension. JAMA. 2012 ; 307 ((20)). 2169-2176
104. Kapa S, Kuniyoshi FHS, Somers VK. Sleep apnea and hypertension: interactions and implications for management. Hypertension. 2008 ; 51 ((3 )). 605-608
105. Pedrosa RP, Krieger EM, Lorenzi G, et al. Recent advances of the impact of obstructive sleep apnea on systemic hypertension. Arq Bras Cardiol. 2011 ; 97 ((2)). E40 - E47
106. Moller DS, Lind P, Strunge B, et al. Abnormal vasoactive hormones and 24-h blood pressure in obstructive sleep apnea. Am J Hypertens. 2003 ; 16 ((4)). 274-280
107. Monahan K, Redline S. Role of obstructive sleep apnea in cardiovascular disease. Curr Opin Cardiol. 2011 ; 26 ((6 )). 541-547
108. Drager LF, Lopes HF, Maki-Nunes C, et al. The impact of obstructive sleep apnea on metabolic and inflammatory markers in consecutive patients with metabolic syndrome. PLoS ONE. 2010 ; 5 ((8)). e12065
109. Newman AB, Nieto FJ, Guidry U, et al. Relation of sleep-disordered breathing to cardiovascular disease risk factors: the sleep heart health study. Am J Epidemiol. 2001 ; 154 ((1)). 50-59
110. Borgel J, Sanner BM, Bittlinsky A, et al. Obstructive sleep apnoea and its therapy influence high-density lipoprotein cholesterol serum levels. Eur Resp J. 2006 ; 27 ((1)). 121-127
111. Drager LF, Jun J, Polotsky VY. Obstructive sleep apnea and dyslipidemia: implications for atherosclerosis. Curr Opin Endocrinol Diabetes Obes. 2010 ; 17 ((2)). 161-165
112. Drager LF, Li JG, Shin MK, et al. Intermittent hypoxia inhibits clearance of triglyceride-rich lipoproteins and inactivates adipose lipoprotein lipase in a mouse model of sleep apnoea. Eur Heart J. 2012 ; 33 ((6)). 783-790
113. Drager LF, Yao QL, Hernandez KL, et al. Chronic intermittent hypoxia induces atherosclerosis via activation of adipose angiopoietin-like 4. Am J Respir Crit Care Med. 2013 ; 188 ((2)). 240-248
114. Jun J, Polotsky VY. Metabolic consequences of sleep-disordered breathing. Ilar J. 2009 ; 50 ((3 )). 289-306
115. Ballester E, Badia JR, Hernandez L, et al. Evidence of the effectiveness of continuous positive airway pressure in the treatment of sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med. 1999 ; 159 ((2)). 495-501
116. Jenkinson C, Davies RJO, Mullins R, et al. Comparison of therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised prospective parallel trial. Lancet. 1999 ; 353 ((9170)). 2100-2105
117. Surani S, Subramanian S. Effect of continuous positive airway pressure therapy on glucose control. World J Diabetes. 2012 ; 3 ((4 )). 65-70
118. Hecht L, Mohler R, Meyer G. Effects of CPAP-respiration on markers of glucose metabolism in patients with obstructive sleep apnoea syndrome: a systematic review and meta-analysis. Ger Med Sci. 2011 ; 9: Doc20
119. Iftikhar IH, Blankfield RP. Effect of continuous positive airway pressure on hemoglobin A(1c) in patients with obstructive sleep apnea: a systematic review and meta-analysis. Lung. 2012 ; 190 ((6)). 605-611
120. Harsch IA, Schahin SP, Radespiel-Troger M, et al. Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome. Am J Respir Crit Care Med. 2004 ; 169 ((2)). 156-162
121. Dawson A, Abel SL, Loving RT, et al. CPAP therapy of obstructive sleep apnea in type 2 diabetics improves glycemic control during sleep. J Clin Sleep Med. 2008 ; 4 ((6)). 538-542
122. Babu AR, Herdegen J, Fogelfeld L, et al. Type 2 diabetes, glycemic control, and continuous positive airway pressure in obstructive sleep apnea. Arch Intern Med. 2005 ; 165 ((4)). 447-452
123. Lam JCM, Lam B, Yao TJ, et al. A randomised controlled trial of nasal continuous positive airway pressure on insulin sensitivity in obstructive sleep apnoea. Eur Resp J. 2010 ; 35 ((1)). 138-145
124. Weinstock TG, Wang X, Rueschman M, et al. A controlled trial of CPAP therapy on metabolic control in individuals with impaired glucose tolerance and sleep apnea. Sleep. 2012 ; 35 ((5)). 617-625
125. West SD, Nicoll DJ, Wallace TM, et al. Effect of CPAP on insulin resistance and HbA1c in men with obstructive sleep apnoea and type 2 diabetes. Thorax. 2007 ; 62 ((11)). 969-974
126. Pepin JL, Tamisier R, Levy P. Obstructive sleep apnoea and metabolic syndrome: put CPAP efficacy in a more realistic perspective. Thorax. 2012 ; 67 ((12)). 1025-1027
127. Gillies CL, Abrams KR, Lambert PC, et al. Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis. Br Med J. 2007 ; 334 ((7588)). 299
128. Tuomilehto J. Non-pharmacologic therapy and exercise in the prevention of type 2 diabetes. Diabetes Care. 2009 ; 32: S189 - S193
129. Guest JF, Panca M, Sladkevicius E, et al. Clinical outcomes and cost-effectiveness of continuous positive airway pressure to manage obstructive sleep apnea in patients with type 2 diabetes in the U.K. Diabetes Care. 2014 ; 37 ((5)). 1263-1271
130. Comondore VR, Cheema R, Fox J, et al. The impact of CPAP on cardiovascular biomarkers in minimally symptomatic patients with obstructive sleep apnea: a pilot feasibility randomized crossover trial. Lung. 2009 ; 187 ((1)). 17-22
131. Hoyos CM, Killick R, Yee BJ, et al. Cardiometabolic changes after continuous positive airway pressure for obstructive sleep apnoea: a randomised sham-controlled study. Thorax. 2012 ; 67 ((12)). 1081-1089
132. Coughlin SR, Mawdsley L, Mugarza JA, et al. Cardiovascular and metabolic effects of CPAP in obese males with OSA. Eur Resp J. 2007 ; 29 ((4 )). 720-727
133. Hoyos CM, Sullivan DR, Liu PY. Effect of CPAP on the metabolic syndrome: a randomised sham-controlled study. Thorax. 2013 ; 68 ((6 )). 588-589
134. Haentjens P, Van Meerhaeghe A, Moscariello A, et al. The impact of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea syndrome: evidence from a meta-analysis of placebo-controlled randomized trials. Arch Intern Med. 2007 ; 167 ((8)). 757-765
135. Bonsignore MR, McNicholas WT, Montserrat JM, et al. Adipose tissue in obesity and obstructive sleep apnoea. Eur Resp J. 2012 ; 39 ((3 )). 746-767
136. Robinson GV, Pepperell JCT, Segal HC, et al. Circulating cardiovascular risk factors in obstructive sleep apnoea: data from randomised controlled trials. Thorax. 2004 ; 59 ((9)). 777-782
137. Phillips CL, Yee BJ, Marshall NS, et al. Continuous positive airway pressure reduces postprandial lipidemia in obstructive sleep apnea a randomized, placebo-controlled crossover trial. Am J Respir Crit Care Med. 2011 ; 184 ((3)). 355-361
138. Kritikou I, Basta M, Vgontzas AN, et al. Sleep apnoea, sleepiness, inflammation and insulin resistance in middle-aged males and females. Eur Resp J. 2014 ; 43 ((1)). 145-155
139. Kuna ST, Reboussin DM, Borradaile KE, et al. Long-term effect of weight loss on obstructive sleep apnea severity in obese patients with type 2 diabetes. Sleep. 2013 ; 36 ((5)). 641-649
140. Tuomilehto HPI, Seppa JM, Partinen MM, et al. Lifestyle intervention with weight reduction first-line treatment in mild obstructive sleep apnea. Am J Respir Crit Care Med. 2009 ; 179 ((4)). 320-327
141. Tuomilehto H, Seppa J, Uusitupa M, et al. Weight reduction and increased physical activity to prevent the progression of obstructive sleep apnea: a 4-year observational postintervention follow-up of a randomized clinical trial. JAMA Intern Med. 2013 ; 173 ((10)). 930-932
142. Kline CE, Crowley EP, Ewing GB, et al. The effect of exercise training on obstructive sleep apnea and sleep quality: a randomized controlled trial. Sleep. 2011 ; 34 ((12)). 1631-1640
143. Kajaste S, Brander PE, Telakivi T, et al. A cognitive-behavioral weight reduction program in the treatment of obstructive sleep apnea syndrome with or without initial nasal CPAP: a randomized study. Sleep Med. 2004 ; 5 ((2)). 125-131
144. Thomasouli MA, Brady EM, Davies MJ, et al. The impact of diet and lifestyle management strategies for obstructive sleep apnoea in adults: a systematic review and meta-analysis of randomised controlled trials. Sleep Breath. 2013 ; 17 ((3)). 925-935
145. Chirinos JA, Gurubhagavatula I, Teff K, et al. CPAP, weight loss, or both for obstructive sleep apnea. N Engl J Med. 2014 ; 370 ((24 )). 2265-2275
146. Dixon JB, Schachter LM, O'Brien PE, et al. Surgical vs conventional therapy for weight loss treatment of obstructive sleep apnea a randomized controlled trial. JAMA. 2012 ; 308 ((11)). 1142-1149
147. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004 ; 292 ((14 )). 1724-1737
148. Veasey SC, Guilleminault C, Strohl KP, et al. Medical therapy for obstructive sleep apnea: a review by the medical therapy for obstructive sleep apnea task force of the standards of Practice Committee of the American Academy of Sleep Medicine. Sleep. 2006 ; 29 ((8)). 1036-1044
149. Ashrafian H, le Roux CW, Rowland SP, et al. Metabolic surgery and obstructive sleep apnoea: the protective effects of bariatric procedures. Thorax. 2012 ; 67 ((5)). 442-449
150. Dixon JB, O'Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA. 2008 ; 299 ((3)). 316-323
151. Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012 ; 366 ((17)). 1567-1576